Thursday, January 4, 2018

Carfilzomib linked to higher rates of cardiovascular problems

Analysis of clinical trial data shows that patients taking cancer drug are twice as likely to experience adverse cardiac issues

via Chemical & Engineering News: Biological SCENE http://ift.tt/2lVymWU
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)